Your browser doesn't support javascript.
loading
Management of opioid use disorder, opioid withdrawal, and opioid overdose prevention in hospitalized adults: A systematic review of existing guidelines.
Calcaterra, Susan L; Bottner, Richard; Martin, Marlene; Englander, Honora; Weinstein, Zoe M; Weimer, Melissa B; Lambert, Eugene; Ronan, Matthew V; Huerta, Sergio; Zaman, Tauheed; Ullal, Monish; Peterkin, Alyssa F; Torres-Lockhart, Kristine; Buresh, Megan; O'Brien, Meghan T; Snyder, Hannah; Herzig, Shoshana J.
Afiliação
  • Calcaterra SL; Department of Medicine, Division of General Internal Medicine and Division of Hospital Medicine, University of Colorado, Aurora, Colorado, USA.
  • Bottner R; Department of Internal Medicine, Dell Medical School at The University of Texas at Austin, Austin, Texas, USA.
  • Martin M; Department of Medicine, Division of Hospital Medicine, University of California San Francisco and San Francisco General Hospital, San Francisco, California, USA.
  • Englander H; Department of Medicine, Section of Addiction Medicine and Division of Hospital Medicine, Oregon Health & Science University, Portland, Oregon, USA.
  • Weinstein ZM; Department of Medicine, Boston Medical Center, Section of General Internal Medicine, Clinical Addiction Research and Education (CARE) Unit, Boston University School of Medicine, Boston, Massachusetts, USA.
  • Weimer MB; Department of Medicine, Yale School of Medicine, New Haven, Connecticut, USA.
  • Lambert E; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.
  • Ronan MV; Department of Medicine, Massachusetts General Hospital, Charlestown, Massachusetts, USA.
  • Huerta S; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.
  • Zaman T; Department of Medicine, Massachusetts General Hospital, Charlestown, Massachusetts, USA.
  • Ullal M; Department of Medicine, VA Boston Healthcare System, West Roxbury, Massachusetts, USA.
  • Peterkin AF; Department of Internal Medicine, Division of Hospital Medicine, University of New Mexico School of Medicine, Albuquerque, New Mexico, USA.
  • Torres-Lockhart K; San Francisco VA Medical Center, San Francisco, California, USA.
  • Buresh M; Department of Psychiatry and Behavioral Sciences, University of California San Francisco, San Francisco, California, USA.
  • O'Brien MT; Department of Internal Medicine at Highland Hospital, Alameda Health System, Oakland, California, USA.
  • Snyder H; Department of Medicine, Boston Medical Center, Section of General Internal Medicine, Clinical Addiction Research and Education (CARE) Unit, Boston University School of Medicine, Boston, Massachusetts, USA.
  • Herzig SJ; Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, New York, USA.
J Hosp Med ; 17(9): 679-692, 2022 09.
Article em En | MEDLINE | ID: mdl-35880821
ABSTRACT

BACKGROUND:

Hospitalizations related to the consequences of opioid use are rising. National guidelines directing in-hospital opioid use disorder (OUD) management do not exist. OUD treatment guidelines intended for other treatment settings could inform in-hospital OUD management.

OBJECTIVE:

Evaluate the quality and content of existing guidelines for OUD treatment and management. DATA SOURCES OVID MEDLINE, PubMed, Ovid PsychINFO, EBSCOhost CINHAL, ERCI Guidelines Trust, websites of relevant societies and advocacy organizations, and selected international search engines. STUDY SELECTION Guidelines published between January 2010 to June 2020 addressing OUD treatment, opioid withdrawal management, opioid overdose prevention, and care transitions among adults. DATA EXTRACTION We assessed quality using the Appraisal of Guidelines for Research and Evaluation (AGREE) II instrument. DATA

SYNTHESIS:

Nineteen guidelines met the selection criteria. Most recommendations were based on observational studies or expert consensus. Guidelines recommended the use of nonstigmatizing language among patients with OUD; to assess patients with unhealthy opioid use for OUD using the Diagnostic Statistical Manual of Diseases-5th Edition criteria; use of methadone or buprenorphine to treat OUD and opioid withdrawal; use of multimodal, nonopioid therapy, and when needed, short-acting opioid analgesics in addition to buprenorphine or methadone, for acute pain management; ensuring linkage to ongoing methadone or buprenorphine treatment; referring patients to psychosocial treatment; and ensuring access to naloxone for opioid overdose reversal.

CONCLUSIONS:

Included guidelines were informed by studies with various levels of rigor and quality. Future research should systematically study buprenorphine and methadone initiation and titration among people using fentanyl and people with pain, especially during hospitalization.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Buprenorfina / Overdose de Opiáceos / Transtornos Relacionados ao Uso de Opioides Limite: Adult / Humans Idioma: En Ano de publicação: 2022

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Buprenorfina / Overdose de Opiáceos / Transtornos Relacionados ao Uso de Opioides Limite: Adult / Humans Idioma: En Ano de publicação: 2022